Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $1.2 million.

  • bioAffinity Technologies' Other Operating Expenses fell 2981.76% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 1351.36%. This contributed to the annual value of $6.7 million for FY2024, which is 23506.41% up from last year.
  • Per bioAffinity Technologies' latest filing, its Other Operating Expenses stood at $1.2 million for Q3 2025, which was down 2981.76% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Other Operating Expenses peaked at $1.8 million during Q4 2024, and registered a low of -$16999.0 during Q4 2022.
  • Over the past 4 years, bioAffinity Technologies' median Other Operating Expenses value was $1.2 million (recorded in 2025), while the average stood at $856808.7.
  • Examining YoY changes over the last 5 years, bioAffinity Technologies' Other Operating Expenses showed a top increase of 1035185.6% in 2023 and a maximum decrease of 6245.17% in 2023.
  • bioAffinity Technologies' Other Operating Expenses (Quarter) stood at -$16999.0 in 2022, then surged by 10351.86% to $1.7 million in 2023, then increased by 3.32% to $1.8 million in 2024, then plummeted by 35.89% to $1.2 million in 2025.
  • Its Other Operating Expenses stands at $1.2 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.6 million for Q1 2025.